{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:54:35Z","timestamp":1792587275705,"version":"4.5.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Joint arthroplasty effectively treats osteoarthritis, providing pain relief and improving function, but postoperative venous thromboembolism (VTE) remains a common complication. This study therefore assessed the effectiveness and safety of aspirin compared with oral anticoagulants (OACs) for VTE prophylaxis after joint arthroplasty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis was performed by searching PubMed, Embase, the Web of Science, and the Cochrane Library for randomized controlled trials (RCTs) up to May 14, 2024, that compared the effect of aspirin versus OACs on VTE prophylaxis in adults undergoing joint arthroplasty. Data extraction followed the PRISMA guidelines. Two independent researchers conducted the literature searches and data extraction. A random-effects model was used to estimate effects. The primary outcome was the incidence of VTE, including deep vein thrombosis (DVT) and pulmonary embolism (PE); secondary outcomes included bleeding, wound complications, and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The meta-analysis included 11 RCTs with a total of 4,717 participants (55.1% female) from several continents. The relative risk (RR) of VTE following joint arthroplasty was 1.11 (95% confidence interval [CI], 0.93 to 1.32) for aspirin compared with OACs. Similar results were observed for DVT (RR, 1.12; 95% CI, 0.90 to 1.40) and PE (RR, 1.18; 95% CI, 0.51 to 2.71). There were no significant differences in the risks of bleeding, wound complications, or mortality between patients receiving aspirin and those receiving OACs. Subgroup analyses considering factors such as study region, type of joint surgery, type of VTE detection, year of publication, use of mechanical VTE prophylaxis, aspirin dose, type of OAC comparator, study quality, and funding also found no significant differences in VTE incidence between aspirin and OACs. The overall quality of evidence for VTE and DVT outcomes was high.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Based on high-quality evidence from RCTs, aspirin is as effective and safe as OACs in preventing VTE, including DVT and PE, after joint arthroplasty, without increasing complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>\n                      Therapeutic\n                      <jats:underline>Level I<\/jats:underline>\n                      . See Instructions for Authors for a complete description of levels of evidence.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.24.00946","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T14:01:07Z","timestamp":1737468067000},"page":"760-770","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Aspirin Is as Effective and Safe as Oral Anticoagulants for Venous Thromboembolism Prophylaxis After Joint Arthroplasty"],"prefix":"10.2106","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1856-888X","authenticated-orcid":false,"given":"Zhenghua","family":"Hong","sequence":"first","affiliation":[{"name":"Department of Orthopedics, Taizhou Hospital of Zhejiang Province affiliated with Wenzhou Medical University, Taizhou, Zhejiang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4839-4171","authenticated-orcid":false,"given":"Yongwei","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3491-5686","authenticated-orcid":false,"given":"Liwei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Taizhou Hospital of Zhejiang Province affiliated with Wenzhou Medical University, Taizhou, Zhejiang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4099-6570","authenticated-orcid":false,"given":"Hua","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Taizhou Hospital of Zhejiang Province affiliated with Wenzhou Medical University, Taizhou, Zhejiang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"issue":"8","key":"bib1-20250714","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.3390\/jcm9082467","article-title":"Prevention of Venous Thromboembolism in 2020 and Beyond","volume":"9","author":"Nicholson","year":"2020","journal-title":"J Clin Med."},{"issue":"4","key":"bib2-20250714","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.3390\/ijms24043169","article-title":"A Comprehensive Review of Risk Factors for Venous Thromboembolism: From Epidemiology to Pathophysiology","volume":"24","author":"Pastori","year":"2023","journal-title":"Int J Mol Sci."},{"issue":"8","key":"bib3-20250714","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.arth.2023.02.028","article-title":"Safety and Efficacy of Rivaroxaban in Primary Total Hip and Knee Arthroplasty","volume":"38","author":"Piple","year":"2023","journal-title":"J Arthroplasty."},{"issue":"7","key":"bib4-20250714","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.arth.2021.01.072","article-title":"Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Revision Hip and Knee Arthroplasty as Reported by American Board of Orthopaedic Surgery Part II Candidates","volume":"36","author":"Runner","year":"2021","journal-title":"J Arthroplasty."},{"issue":"7S","key":"bib5-20250714","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/j.arth.2018.03.001","article-title":"Low-Dose Aspirin Is Safe and Effective for Venous Thromboembolism Prophylaxis Following Total Knee Arthroplasty","volume":"33","author":"Faour","year":"2018","journal-title":"J Arthroplasty."},{"issue":"12","key":"bib6-20250714","doi-asserted-by":"crossref","first-page":"e2345883","DOI":"10.1001\/jamanetworkopen.2023.45883","article-title":"Venous Thromboembolism in Total Hip and Total Knee Arthroplasty","volume":"6","author":"Simon","year":"2023","journal-title":"JAMA Netw Open."},{"issue":"3","key":"bib7-20250714","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jamainternmed.2019.6108","article-title":"Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials","volume":"180","author":"Matharu","year":"2020","journal-title":"JAMA Intern Med."},{"issue":"2","key":"bib8-20250714","first-page":"163","article-title":"[Comparative study between enoxaparin and salicylic acetyl acid in antithrombotic prophylaxis for patients undergoing total knee arthroplasty]","volume":"35","author":"Cortes-De la Fuente","year":"2021","journal-title":"Acta Ortop Mex."},{"issue":"2","key":"bib9-20250714","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.arth.2005.04.031","article-title":"Deep vein thrombosis prevention in joint arthroplasties: continuous enhanced circulation therapy vs low molecular weight heparin","volume":"21","author":"Gelfer","year":"2006","journal-title":"J Arthroplasty."},{"issue":"2","key":"bib10-20250714","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest."},{"key":"bib11-20250714","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ."},{"key":"bib12-20250714","volume":"version 6.5","year":"2024","journal-title":"Cochrane Handbook for Systematic Reviews of Interventions"},{"issue":"71","key":"bib13-20250714","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"issue":"10","key":"bib14-20250714","first-page":"ED000142","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"issue":"4","key":"bib15-20250714","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol."},{"issue":"8","key":"bib16-20250714","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1712746","article-title":"Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty","volume":"378","author":"Anderson","year":"2018","journal-title":"N Engl J Med."},{"issue":"1","key":"bib17-20250714","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.rbo.2016.12.004","article-title":"Venous thromboembolism prophylaxis after total knee arthroplasty (TKA): aspirin vs. rivaroxaban","volume":"53","author":"Colleoni","year":"2017","journal-title":"Rev Bras Ortop."},{"issue":"5","key":"bib18-20250714","first-page":"741","article-title":"Aspirin versus Rivaroxaban to Prevent Venous Thromboembolism after Total Knee Arthroplasty: A Double-blinded, Randomized Controlled Trial","volume":"57","author":"Hongnaparak","year":"2021","journal-title":"Rev Bras Ortop (Sao Paulo)."},{"issue":"5","key":"bib19-20250714","doi-asserted-by":"crossref","first-page":"18","DOI":"10.53350\/pjmhs2216518","article-title":"Comparison of the Efficacy of Aspirin with Rivaroxaban in Postoperative DVT Prophylaxis after Hip Arthroplasty in patients at tertiary care hospital","volume":"16","author":"Jatoi","year":"2022","journal-title":"Pakistan Journal of Medical and Health Sciences."},{"issue":"12","key":"bib20-20250714","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.3760\/cma.j.issn.0366-6999.20132175","article-title":"Aspirin combined with mechanical measures to prevent venous thromboembolism after total knee arthroplasty: a randomized controlled trial","volume":"127","author":"Jiang","year":"2014","journal-title":"Chin Med J (Engl)."},{"key":"bib21-20250714","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00003086-199603000-00031","article-title":"Aspirin and warfarin for thromboembolic disease after total joint arthroplasty","volume":"324","author":"Lotke","year":"1996","journal-title":"Clin Orthop Relat Res."},{"issue":"2","key":"bib22-20250714","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/CM9.0000000000001305","article-title":"Comparable efficacy of 100 mg aspirin twice daily and rivaroxaban for venous thromboembolism prophylaxis following primary total hip arthroplasty: a randomized controlled trial","volume":"134","author":"Ren","year":"2021","journal-title":"Chin Med J (Engl)."},{"issue":"23","key":"bib23-20250714","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM197106102842303","article-title":"Reduction in venous thromboembolism by agents affecting platelet function","volume":"284","author":"Salzman","year":"1971","journal-title":"N Engl J Med."},{"issue":"4","key":"bib24-20250714","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2106\/00004623-199173040-00005","article-title":"Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin","volume":"73","author":"Woolson","year":"1991","journal-title":"J Bone Joint Surg Am."},{"issue":"1","key":"bib25-20250714","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12891-022-06117-8","article-title":"Effectiveness of different antithrombotic agents in combination with tranexamic acid for venous thromboembolism prophylaxis and blood management after total knee replacement: a prospective randomized study","volume":"24","author":"Zhou","year":"2023","journal-title":"BMC Musculoskelet Disord."},{"issue":"13","key":"bib26-20250714","first-page":"2012","article-title":"Administration of aspirin and rivaroxaban prevents deep vein thrombosis after total knee arthroplasty","volume":"18","author":"Zou","year":"2014","journal-title":"Chinese Journal of Tissue Engineering Research."},{"key":"bib27-20250714","doi-asserted-by":"crossref","first-page":"1326224","DOI":"10.3389\/fphar.2023.1326224","article-title":"Comparison of efficacy and safety between aspirin and oral anticoagulants for venous thromboembolism prophylaxis after major orthopaedic surgery: a meta-analysis of randomized clinical trials","volume":"14","author":"Zheng","year":"2024","journal-title":"Front Pharmacol."},{"issue":"12","key":"bib28-20250714","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1530\/EOR-22-0053","article-title":"Clinical effectiveness and safety of aspirin and other anticoagulants for venous thromboembolism prophylaxis after major orthopedic surgery: a systematic review and meta-analysis of randomized clinical trials","volume":"7","author":"Singjie","year":"2022","journal-title":"EFORT Open Rev."},{"issue":"3","key":"bib29-20250714","first-page":"e36464","article-title":"Incidence of Symptomatic Venous Thromboembolism (VTE) in 8,885 Elective Total Hip Arthroplasty Patients Receiving Post-operative Aspirin VTE Prophylaxis","volume":"15","author":"Coveney","year":"2023","journal-title":"Cureus."},{"issue":"16","key":"bib30-20250714","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJMoa1401105","article-title":"Aspirin in patients undergoing noncardiac surgery","volume":"370","author":"Devereaux","year":"2014","journal-title":"N Engl J Med."},{"issue":"10","key":"bib31-20250714","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1177\/10711007221112922","article-title":"Cost-Effective Modeling of Thromboembolic Chemoprophylaxis for Total Ankle Arthroplasty","volume":"43","author":"Martinazzi","year":"2022","journal-title":"Foot Ankle Int."}],"container-title":["Journal of Bone and Joint Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.24.00946","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:44:59Z","timestamp":1787751899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.24.00946"}},"subtitle":["A Systematic Review and Meta-Analysis of Randomized Clinical Trials"],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.24.00946","relation":{},"ISSN":["0021-9355","1535-1386"],"issn-type":[{"value":"0021-9355","type":"print"},{"value":"1535-1386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]}}}